Location History:
- Minneapolis, MN (US) (2003 - 2006)
- Thousand Oaks, CA (US) (2013 - 2023)
- Northridge, CA (US) (2024)
Company Filing History:
17 out of 1,224 
1 out of 203 
1 out of 8,734 Years Active: 2003-2025
Title: The Innovative Contributions of Kiem H. Dang in Medication Infusion Technology
Introduction: Kiem H. Dang, an inventor based in Thousand Oaks, California, has made significant contributions to the field of medical technology. With 16 patents to his name, he has focused on creating advanced solutions to improve the quality of care for diabetic patients. His inventive work primarily revolves around medication infusion systems, showcasing his commitment to enhancing patient health outcomes.
Latest Patents: One of Kiem H. Dang's latest patents addresses the development of medication infusion components and systems, specifically designed for the infusing of essential medications like insulin. This innovative system allows for the delivery of insulin to diabetic patients over a period exceeding four days. Key components of the system include a cannula designed for subcutaneous insertion, a fluid conduit for transferring the insulin solution, and a depot that interacts with the fluid conduit. The depot contains specialized materials, including a site-loss mitigating agent such as heparin, which helps reduce inflammation at the infusion site. Notably, this agent is not pre-mixed with insulin; instead, it interacts with the insulin solution as it flows from the reservoir, promoting effective delivery and minimizing potential complications.
Career Highlights: Kiem H. Dang's career is prominently marked by his affiliation with Medtronic MiniMed, Inc., a leader in diabetes management technology. His role has allowed him to innovate in the domain of medication infusion systems, reinforcing the company's reputation for creating reliable and effective health solutions.
Collaborations: Throughout his career, Kiem has worked alongside talented individuals such as Sarnath Chattaraj and Poonam S. Gulati. This collaboration with other skilled professionals has complemented his innovative endeavors, leading to advancements in the technology that benefits diabetic patients.
Conclusion: Kiem H. Dang's work exemplifies the potential of innovation in the medical field, particularly in improving patient care for those living with diabetes. Through his patents and collaborative efforts, he continues to push the boundaries of medication infusion technology, making a profound impact on the future of healthcare and patient management.